Total Funding
69
50
Total FundingPrivate Equity raised
Growth Score 69 in past quarter
-3 pts
Heat Score 50 in past quarter
-6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
30820
PanTheryx is a nutrition and biotechnology company that utilizes the cellular and biomolecular processes of bovine colostrum.
- Robert H. Driver: President, Operations and ManufacturingPast Role: Pfizer, Executive and Management Positions
- Amy M. Gibbs: ControllerPast Role: Applied Films Corporation, Finance Manager
About the Company
PanTheryx is a U.S. medical nutrition company focused on the research, development, and commercialization of products that promote intestinal health. The company is engaged in the discovery and development of its proprietary technology platform, advancing clinical testing, and the commercialization of its products that both address the specific
dietary needs of children with infectious diarrhea, and support overall intestinal health.
The company’s medical nutrition products are regulated in three FDA categories: medical foods, food for special dietary use, and dietary supplements.
PanTheryx was founded in 2007 by Mark A. Braman and is based in Boulder, Colorado.
Women Founded